Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Profile Therapeutics in £25 million bid talks:

This article was originally published in Clinica

Executive Summary

Profile Therapeutics, the UK inhaler company, said it is in talks that could lead to a cash offer of 50p per share for the company, valuing it at just under £25m ($45.8m). It cautioned, however, that there was "no certainty as to the level of any such offer or indeed whether any firm offer will actually be made". The potential bidder was not named. The Bognor Regis-based firm reported first-half sales (to December 31 2003) up by 13% to £7.1m earlier this week. It cut its operating loss by 33% to £1.8m. Profile's partners include Schering AG, CoTherix and Invacare.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts